insulin resistance glp-1 GLP-1/glucagon receptor co-agonism for treatment of obesity | Diabetologia GLP-1 improves adipose tissue glyoxalase

Just hours after her first shot, she felt euphoric

Common side effects include: Nausea and an unsettled stomach, particularly in the early weeks of treatment Vomiting in some cases, especially when doses are increased Digestive changes including constipation or diarrhea Reduced appetite, which is partly how these medications support weight loss Rare but serious side effects include: Pancreatitis: inflammation of the pancreas, which requires immediate medical attention Gallbladder complications such as gallstones or cholecystitis A theoretical risk of medullary thyroid carcinoma has been observed in animal studies, though this has not been confirmed in human clinical data Most common side effects are temporary and tend to ease as your body adjusts to the medication

No GLP-1 medications are specifically contraindicated in Hashimoto's thyroiditis

showed that TMAO production was dependent on the gut microbiota and that mice treated with antibiotics failed to provide the required gut microbiota for TMAO production (7)